The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database

BACKGROUND: Immunotherapy has paved the way for new therapeutic opportunities in cancer but has failed to show any efficacy in Pancreatic Adenocarcinoma (PDAC), and its therapeutic role remains unclear. The objective of this study is to examine the impact of immunotherapy in combination with chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Saber, Baine, Michael, Meza, Jane, Alam, Morshed, Lin, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268762/
https://www.ncbi.nlm.nih.gov/pubmed/32493354
http://dx.doi.org/10.1186/s13014-020-01569-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268762/
https://www.ncbi.nlm.nih.gov/pubmed/32493354
http://dx.doi.org/10.1186/s13014-020-01569-5

Ejemplares similares